Aurora Spine, Inc. (TSXV: ASG) announced today that the first European surgical implant of the Company's ZIP™ MIS Interspinous Implant was performed at the Casa di Cura Rugani, in Sienna Italy.


Aurora Spine, Inc. (TSXV: ASG) announced today that the first European surgical implant of the Company's ZIP™ MIS Interspinous Implant was performed at the Casa di Cura Rugani, in Sienna Italy. The procedure was performed by Professor Dr. Daniel Cabezas, a Neurosurgeon with an expertise in MIS spine surgery. Dr. Daniel Cabezas is a Professor at University of Rome Tor Vergata.

"We are pleased to begin commercialization of the Aurora ZIP™ MIS Interspinous Fusion System in Europe and would like to thank Dr. Daniel Cabezas for performing the procedure, said Trent J. Northcutt, President and CEO of Aurora Spine Inc. Over the remainder of the year we will train additional spine surgeons on our technology, which will support a broader launch in Europe beginning in 2014. We passionately believe the ZIP MIS Interspinous Fusion Systems represents a significant opportunity to provide a better spinal fusion option for doctors, hospital systems, and patients globally and that it will be a growth driver for the Company."

About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements
This statement contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this statement includes information concerning the initial public offering and the use of proceeds in connection therewith. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included, including the risk that the use of proceeds of the offering will not be made in the manner disclosed in the final prospectus. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out in Aurora Spine's final prospectus or herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date stated above and Aurora Spine does not assume any obligation to update or revise them to reflect circumstances.

Company Contact Information
Aurora Spine, Inc.
Tanya Hamze
1920 Palomar Point Way
Carlsbad
92008
760-298-9848

Press Release Service by I-Newswire

Original Source: Aurora Spine, Inc. Announces First ZIP MIS ISP Spinal Procedure Conducted in Europe